UPDATE 2-Cancer drug developer CG Oncology valued at $1.75 …

Jan 25, 2024 · Cancer drug developer CG Oncology notched up a valuation of $1.75 billion in its market debut on Thursday, after its shares jumped 52.6% at the open, as new listings pick up …

CouponFollow Extension

6%
OFF

UPDATE 2-Cancer Drug Developer CG Oncology Valued At $1.75 …

21 hours ago

Jan 25, 2024 · Cancer drug developer CG Oncology notched up a valuation of $1.75 billion in its market debut on Thursday, after its shares jumped 52.6% at the open, as new listings pick up …

yahoo.com

6%
OFF

Cancer Drug Developer CG Oncology Valued At $1.75 Bln In Strong …

21 hours ago

Jan 25, 2024 · Cancer drug developer CG Oncology notched up a valuation of $1.75 billion in its market debut on Thursday, after its shares jumped 52.6% at the open, as new listings pick up …

reuters.com

6%
OFF

CG Oncology Valued At $1.75 Bln In Strong Market Debut - Nasdaq

21 hours ago

Jan 25, 2024 · Cancer drug developer CG Oncology notched up a valuation of $1.75 billion in its market debut on Thursday, after its shares jumped 52.6% at the open, as demand for new …

nasdaq.com

$1.75
OFF

CG Oncology, Inc. (CGON) Stock Price, Quote & News - Stock …

21 hours ago

5 days ago · CG Oncology's Lead Bladder Cancer Drug Offers A Strong Potential Revenue Stream With Buyout Optionality ... Seeking Alpha. CG Oncology valued at $1.75 bln in strong …

stockanalysis.com

6%
OFF

CG Oncology Valued At $1.75 Bln In Strong Market Debut - Yahoo …

21 hours ago

CG Oncology notched up a valuation of $1.75 billion in its market debut on Thursday, after shares of the cancer drug developer rose 52.6% at the open on the Nasdaq.

yahoo.com

$306
OFF

UPDATE 2-Drug Developer CG Oncology Targets Up To $306 Mln …

21 hours ago

Jan 23 (Reuters) - Cancer drug developer CG Oncology said on Tuesday it was aiming to raise up to $306 million in its upsized initial public offering in New York, underscoring the resurgent …

yahoo.com

6%
OFF

Cancer Drug Developer CG Oncology Valued At $1.75 Billion In …

21 hours ago

Jan 25, 2024 · (Reuters) -Cancer drug developer CG Oncology notched up a valuation of $1.75 billion in its market debut on Thursday, after its shares jumped 52.6% at the open, as new …

yahoo.com

$1.75
OFF

CG Oncology Inc | Reuters

21 hours ago

Feb 9, 2024 · The latest international CG Oncology Inc news and views from Reuters - one of the world's largest news agencies ... Cancer drug developer CG Oncology valued at $1.75 bln in …

reuters.com

$1
OFF

CG Oncology Targets Near $1 Bln Valuation In US IPO

21 hours ago

Jan 18, 2024 · Adds details on company's business, IPO terms in paragraphs 2-6. Jan 18 (Reuters) - Cancer drug developer CG Oncology said on Thursday it was targeting a valuation …

nasdaq.com

$380
OFF

CG Oncology Prices Larger-than-expected $380M IPO In Hopeful …

21 hours ago

Jan 24, 2024 · Cancer drug developer CG Oncology has raised $380 million in an initial public offering than was larger than it expected, a positive sign for a sector that’s struggled to …

biopharmadive.com

$1
OFF

Cancer Drug Developer CG Oncology Targets Near $1 Bln Valuation …

21 hours ago

Jan 18, 2024 · Cancer drug developer CG Oncology said on Thursday it was targeting a valuation of nearly $1 billion for its initial public offering. Cancer drug developer CG Oncology said on …

yahoo.com

$4.71
OFF

CG Oncology Begins IPO Effort For Bladder Cancer Drug - Seeking …

21 hours ago

Jan 5, 2024 · The global market for bladder cancer treatment is expected to reach $4.71 billion by 2026, driving potential growth for CG Oncology. I'll provide an update when we learn more IPO …

seekingalpha.com

$306
OFF

Drug Developer CG Oncology Targets Up To $306 Mln For Upsized IPO

21 hours ago

Jan 23, 2024 · Adds background, IPO detail in paragraphs 2-6. Jan 23 (Reuters) - Cancer drug developer CG Oncology said on Tuesday it was aiming to raise up to $306 million in its U.S. …

nasdaq.com

$1
OFF

CG Oncology Targets Near $1 Bln Valuation In US IPO | Reuters

21 hours ago

Jan 18 (Reuters) - Cancer drug developer CG Oncology said on Thursday it was targeting a valuation of nearly $1 billion for its initial public offering. The company is developing a therapy …

reuters.com

$1
OFF

UPDATE 1-CG Oncology Targets Near $1 Bln Valuation In US IPO

21 hours ago

Jan 18, 2024 · (Adds details on company's business, IPO terms in paragraphs 2-6) Jan 18 (Reuters) - Cancer drug developer CG Oncology said on Thursday it was targeting a valuation …

yahoo.com

FAQs about UPDATE 2-Cancer drug developer CG Oncology valued at $1.75 … Coupon?

How much is CG oncology worth?

Jan 25 (Reuters) - Cancer drug developer CG Oncology (CGON.O) notched up a valuation of $1.75 billion in its market debut on Thursday, after its shares jumped 52.6% at the open, as new listings pick up pace. ...

Will CG oncology raise $306 million?

Jan 23 (Reuters) - Cancer drug developer CG Oncology said on Tuesday it was aiming to raise up to $306 million in its U.S. initial public offering, higher than it had previously expected. ...

Who is CG oncology?

Irvine, California-based CG Oncology, Inc. was founded to develop its product cretostimogene for the treatment of patients with high-risk Non-Muscle Invasive Bladder Cancer [NMIBC]. ...

Is CG oncology a good buy?

The firm is a late-stage biotech company developing a treatment for bladder cancer. I favor CG Oncology, Inc.'s focus on one cancer type and would not be surprised if the company has significant acquisition interest from major pharma firms. ...

How many shares will CG oncology offer?

CG Oncology did not say how many shares it planned to offer or give an estimated price range. The company plans to use proceeds primarily for supporting operations. The company has applied to list its shares on the Nasdaq Global Market under the ticker CGON. ...

Will CG oncology sell on the NASDAQ?

CG Oncology Inc. on Wednesday filed for an initial public offering to trade on the Nasdaq under the symbol “CGON” with underwriters Morgan Stanley, Goldman Sachs, Cantor and LifeSci Capital. ...